Headquarters
1340 SMITH AVE STE 200, BALTIMORE, MD 21209-3796, US
BALTIMORE, MD, US
AGENEBIO INC
From the company
AgeneBio, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative therapeutics for patients at risk for neurological and psychiatric conditions, with the goal of preserving and restoring brain function. Its lead late-stage clinical program, AGB101, is being evaluated for amnestic mild cognitive impairment due to Alzheimer's disease (MCI due to AD) in the HOPE4MCI Phase 2b trial. It also has a discovery program developing GABA(A) α5 positive allosteric modulators.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (1)
- Woman Owned Business
Facilities
Send your requirements
Quantities, certifications, and timing.